Min Liu, Qiao Huang, Hongkai Zhang
Department of Pathology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Department of Breast Surgery, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Histol Histopathol. 2023 Jan;38(1):91-97. doi: 10.14670/HH-18-501. Epub 2022 Jul 27.
Acinic cell carcinoma of the breast is an extremely rare tumor. To the best of our knowledge, only one case is reported to have bilateral tumors and had both BRCA1 and TP53 mutation. Herein, we report another case of acinic cell carcinoma of the breast in a 29-years-old female carrying germline BRCA1 and TP53 mutation, and the tumor showed a complex combination of histological features which had not only the reported common features such as diffuse infiltrative small acinar or glandular structures mixed with solid nests, but also the uncommon widespread clear cells, high grade tumor cells. The immunohistochemical profile of the tumor cells was strongly positive for lysozyme and triple negative for ER, PR, HER2. Although she had bilateral high grade breast cancers, this patient refused postoperative adjuvant therapy this time and has been doing well in the past 12 months. As a rare form of triple-negative breast cancer with a relatively not so bad prognosis, more reports are needed to understand its biological characteristics.
乳腺腺泡细胞癌是一种极其罕见的肿瘤。据我们所知,仅有一例报告显示双侧肿瘤且同时存在BRCA1和TP53突变。在此,我们报告另一例29岁携带胚系BRCA1和TP53突变的女性乳腺腺泡细胞癌病例,该肿瘤呈现出复杂的组织学特征组合,不仅具有已报道的常见特征,如弥漫浸润性小腺泡或腺管结构混合实性巢状结构,还具有罕见的广泛透明细胞、高级别肿瘤细胞。肿瘤细胞的免疫组化特征显示溶菌酶呈强阳性,雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)呈三阴性。尽管该患者患有双侧高级别乳腺癌,但此次拒绝了术后辅助治疗,在过去12个月里情况良好。作为一种预后相对不太差的罕见三阴性乳腺癌形式,需要更多报告来了解其生物学特性。